NCT07276087

Brief Summary

Systemic vasculitis refers to a group of rare diseases characterized by inflammation of blood vessel walls, which may cause ischemia and structural damage in various organs. Among large-vessel vasculitides, Takayasu arteritis primarily affects the aorta and its main branches, whereas Behçet's disease is a variable vessel vasculitis involving arteries and veins of all sizes. Both conditions can lead to multisystemic involvement and significantly impact physical and psychosocial health. This observational, case-control study aims to compare multiple physical and psychosocial parameters among individuals with Takayasu arteritis, Behçet's disease, and healthy controls. Assessments will include respiratory and peripheral muscle strength, functional status, exercise capacity, body composition, quality of life, illness perception, and psychological well-being. Measurements will be conducted using standardized clinical tests (such as maximal inspiratory and expiratory pressures, handgrip and limb strength dynamometry, squat test, and six-minute walk test) and validated questionnaires (Health Assessment Questionnaire (HAQ), the Short Form-36 Health Survey (SF-36), the EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L), and the Visual Analogue Scale (VAS)). The study seeks to identify differences between groups and provide a comprehensive understanding of how systemic inflammation in Takayasu arteritis and Behçet's disease affects physical performance, quality of life, and psychosocial health. These findings may help guide physiotherapy, rehabilitation, and multidisciplinary management strategies for patients with systemic vasculitis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 11, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 18, 2025

Completed
22 days until next milestone

First Posted

Study publicly available on registry

December 10, 2025

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

December 10, 2025

Status Verified

October 1, 2025

Enrollment Period

4 months

First QC Date

November 18, 2025

Last Update Submit

December 9, 2025

Conditions

Keywords

Takayasu arteritisBehçet's diseaseSystemic vasculitisMuscle strength

Outcome Measures

Primary Outcomes (2)

  • Peripheral muscle strength

    Peripheral muscle strength will be assessed using the Commander Echo™ Muscle Testing Dynamometer (JTECH Medical, USA) for upper and lower extremities. Measurements will include quadriceps, biceps, and shoulder abductor muscle strength. The average of three trials will be recorded in kilograms.

    Single assessment (baseline only)

  • Respiratory Muscle Strength

    Measured by maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) using a portable electronic manometer (Micro Medical MicroMPM, UK).

    Single assessment (baseline only)

Secondary Outcomes (9)

  • Functional Exercise Capacity-Six-Minute Walk Test (6MWT)

    Single session at baseline

  • Functional Status- Health Assessment Questionnaire

    Single session at baseline

  • General Health Perception - Visual Analogue Scale (VAS)

    Single assessment at baseline.

  • Quality of Life - Short Form-36 Health Survey (SF-36)

    Single session at baseline

  • Quality of Life - EuroQol 5-Dimension 5-Level Questionnaire (EQ-5D-5L)

    Single session at baseline.

  • +4 more secondary outcomes

Study Arms (3)

Takayasu Arteritis Group

Participants diagnosed with Takayasu arteritis according to established clinical and imaging criteria.

Other: No intervention (observational study)

Behçet's Disease Group

Participants diagnosed with Behçet's disease according to the International Study Group criteria.

Other: No intervention (observational study)

Healthy Control Group

Age- and sex-matched healthy volunteers with no systemic or chronic disease.

Other: No intervention (observational study)

Interventions

Participants will not receive any treatment or intervention. The study involves only physical and psychosocial assessments and questionnaires.

Behçet's Disease GroupHealthy Control GroupTakayasu Arteritis Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of individuals aged 18 years and older who have been diagnosed with Takayasu arteritis or Behçet's disease and are being followed at the Rheumatology Department of Pamukkale University, as well as age- and sex-matched healthy volunteers without systemic, neurological, or musculoskeletal disease. All participants will provide written informed consent prior to inclusion in the study.

You may qualify if:

  • Age 18 years or older.
  • Diagnosis of Takayasu arteritis according to the American College of Rheumatology (ACR) classification criteria.
  • Voluntary participation with written informed consent.
  • Age 18 years or older.
  • Diagnosis of Behçet's disease according to the International Study Group for Behçet's Disease criteria.
  • Voluntary participation with written informed consent.
  • Age 18 years or older.
  • No history of systemic, rheumatologic, or chronic inflammatory disease.
  • Voluntary participation with written informed consent.

You may not qualify if:

  • Pregnancy.
  • Presence of psychiatric disorder or ongoing psychiatric treatment.
  • Cognitive impairment that may interfere with participation.
  • Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
  • History of any surgical operation within the past year.
  • Coexisting rheumatic disease other than Takayasu arteritis or Behçet's disease.
  • Pregnancy.
  • Presence of psychiatric disorder or ongoing psychiatric treatment.
  • Cognitive impairment that may interfere with participation.
  • Presence of neurological disease (e.g., hemiplegia, Parkinson's disease, multiple sclerosis, vertigo, epilepsy, etc.).
  • History of any surgical operation within the past year.
  • History of rheumatologic or chronic inflammatory disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pamukkale University

Denizli, Denizli, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Takayasu ArteritisBehcet SyndromeSystemic Vasculitis

Interventions

Observation

Condition Hierarchy (Ancestors)

Aortic Arch SyndromesAortic DiseasesVascular DiseasesCardiovascular DiseasesArteritisVasculitisSkin Diseases, VascularSkin DiseasesSkin and Connective Tissue DiseasesMouth DiseasesStomatognathic DiseasesUveitis, AnteriorPanuveitisUveitisUveal DiseasesEye DiseasesHereditary Autoinflammatory DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin Diseases, Genetic

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Özlem Nur Tok Yaman, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Lecturer , Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation

Study Record Dates

First Submitted

November 18, 2025

First Posted

December 10, 2025

Study Start

September 11, 2025

Primary Completion

December 30, 2025

Study Completion

January 30, 2026

Last Updated

December 10, 2025

Record last verified: 2025-10

Locations